166 related articles for article (PubMed ID: 36062783)
1. [Effects of aerobic exercise on CNPY2-PERK pathway in the liver of mice with non-alcoholic fatty liver disease].
Li JH; Xiong W; Wang JQ; Li YL; Jiang CJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Sep; 38(3):193-198. PubMed ID: 36062783
[No Abstract] [Full Text] [Related]
2. Aerobic exercise improves non-alcoholic fatty liver disease by down-regulating the protein expression of the CNPY2-PERK pathway.
Li J; Huang L; Xiong W; Qian Y; Song M
Biochem Biophys Res Commun; 2022 May; 603():35-40. PubMed ID: 35278877
[TBL] [Abstract][Full Text] [Related]
3. [Effect of aerobic exercise on AKT/GSK3β mediated hepatocyte apoptosis in nonalcoholic fatty liver disease].
Wang J; Li Y; Jiang C; Li J
Wei Sheng Yan Jiu; 2023 Mar; 52(2):246-252. PubMed ID: 37062687
[TBL] [Abstract][Full Text] [Related]
4. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
[No Abstract] [Full Text] [Related]
5. [Effects of different swimming exercises on alcoholic fatty liver formation in mice].
Chen R; Chen W; Chen YL; Chen JQ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Jul; 38(4):341-347. PubMed ID: 36414559
[No Abstract] [Full Text] [Related]
6. [Effects of sera of rats fed with
Yang M; Chen Z; Xiao C; Tang W; Zhou B
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1277-1287. PubMed ID: 30514673
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
[TBL] [Abstract][Full Text] [Related]
8. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
Tian X; Xiong Q; Chen L; Wen JR; Ru Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
[No Abstract] [Full Text] [Related]
9. Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
Li R; Zhu W; Huang P; Ding C; Tang Y; Lian P; Huang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):730-738. PubMed ID: 35837772
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
[TBL] [Abstract][Full Text] [Related]
11. [Effects of aerobic exercise combined with
Cui XM; Cao JM; Zhang J; Zhou HT; Niu YL; Hu G; Guo X; Li ZY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jul; 36(4):301-305. PubMed ID: 33167087
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of geniposide in improving free fatty acid metabolism in rats with non-alcoholic fatty liver disease].
Liang HQ; Lin MT; Zhao X; Zhou HH; Wang HG; Li GH; Wang YJ; Zhang LM; Wang YY; Chen SD
Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):470-475. PubMed ID: 28868866
[TBL] [Abstract][Full Text] [Related]
13. BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling.
Sheng D; Zhao S; Gao L; Zheng H; Liu W; Hou J; Jin Y; Ye F; Zhao Q; Li R; Zhao N; Zhang L; Han Z; Wei L
Cell Biosci; 2019; 9():77. PubMed ID: 31548878
[TBL] [Abstract][Full Text] [Related]
14. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
[TBL] [Abstract][Full Text] [Related]
15. [Preventive and therapeutic effects of compound ginkgo extract in rats with nonalcoholic steatohepatitis induced by high-fat, high-fructose diet].
Yang Q; Zhao H; Zhou AZ; Lou ZH
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):852-858. PubMed ID: 27978932
[No Abstract] [Full Text] [Related]
16. [Effects of lycopene on metabolism of glycolipid and inflammation in non-alcoholic fatty liver disease rats].
Zhang P; Li J; Li M; Sui Y; Zhou Y; Sun Y
Wei Sheng Yan Jiu; 2020 Mar; 49(2):254-271. PubMed ID: 32290942
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
[TBL] [Abstract][Full Text] [Related]
18. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
Zhong FW; Li GX; Zeng L
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
[TBL] [Abstract][Full Text] [Related]
19. [Zuogui Jiangtang Qinggan Formula improves glucolipid metabolism in type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease by regulating FoxO1/MTP/APOB signaling pathway].
Xiang YX; Huang YL; Zhou M; Zou JJ; Liu X; Liu ZY; Xiao F; Yu R; Xiang Q
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4438-4445. PubMed ID: 37802870
[TBL] [Abstract][Full Text] [Related]
20. GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis.
Luo X; Shi X; Sun Z; Xiao J; Song H; Lu G; Xu X
Biomed Res Int; 2020; 2020():1454396. PubMed ID: 33299856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]